argenx (NASDAQ:ARGX) Price Target Increased to $478.00 by Analysts at Wells Fargo & Company
argenx (NASDAQ:ARGX – Get Free Report) had its price objective upped by Wells Fargo & Company from $472.00 to $478.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price objective suggests a potential upside of 19.51% from the company’s current […]
More Stories
Lesser-Known Provisions of the House-Passed ‘Big Beautiful Bill’
By Joseph Lord Following its passage by the House in the early morning hours of May 22, the One Big...
Royal Bank of Canada Has $15.51 Million Stake in Paramount Global (NASDAQ:PARA)
Royal Bank of Canada lowered its stake in Paramount Global (NASDAQ:PARA – Free Report) by 6.3% in the fourth quarter,...
LendingClub Co. (NYSE:LC) Shares Acquired by ProShare Advisors LLC
ProShare Advisors LLC increased its position in LendingClub Co. (NYSE:LC – Free Report) by 50.8% in the fourth quarter, according...
BNP Paribas Financial Markets Trims Stock Position in 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS)
BNP Paribas Financial Markets trimmed its holdings in 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS – Free Report) by 22.4% during the 4th quarter,...
Adeia Inc. (NASDAQ:ADEA) Position Reduced by State of Wyoming
State of Wyoming decreased its holdings in Adeia Inc. (NASDAQ:ADEA – Free Report) by 49.2% during the fourth quarter, according...
ProShare Advisors LLC Has $514,000 Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
ProShare Advisors LLC grew its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 27.2% during the...